Skip to main content
. 2012 Feb;74(1-2):39–49.

Table 3.

Initial serum ferritin, ferritin iron, hemosiderin iron and total iron stores in patients with hereditary hemochromatosis (HH), transfusion-dependent anemia (TD), or chronic hepatitis C (CHC) and treated iron deficiency anemia (TIDA)

Patient Initial serum ferritin Ferritin iron Hemosideriniron Total iron stores
Disease No. Sex ng/ml g (%) g (%) g (%)
HH 1 M 10000 8 (27) 22 (73) 30 (100)
HH 2 M 6000 8 (44) 10 (56) 18 (100)
HH 3 M 5000 8 (53) 7 (47) 15 (100)
HH 4 M 3000 7.5 (58) 6.5 (42) 13 (100)
HH 5 M 4000 6 (46) 7 (52) 13 (100)
HH 6 M 1800 1 (25) 3 (75) 4 (100)
HH 7 M 4000 4 (29) 10 (71) 14 (100)
HH 8 M 2200 2 (25) 6 (75) 8 (100)
TD 9 F 8000 7 (26) 19 (74) 26 (100)
TD 10 M 1700 3.2 (70) 1.3 (30) 4.5 (100)
TD 11 M 5800 3.6 (21) 13.4 (79) 17 (100)
CHC 12 M 500 0.5 (33) 1.0 (67) 1.5 (100)
CHC 13 M 200 0.2 (22) 0.7 (78) 0.9 (100)
CHC 14 M 152 0.4 (36) 0.7 (64) 1.1 (100)
CHC 15 M 225 0.4 (50) 0.4 (50) 0.8 (100)
CHC 16 M 128 0.3 (40) 0.4 (60) 0.7 (100)
CHC 17 M 216 0.3 (30) 0.7 (70) 1.0 (100)
CHC 18 M 145 0.4 (50) 0.4 (50) 0.8 (100)
CHC 19 M 132 0.3 (50) 0.3 (50) 0.6 (100)
CHC 20 M 81 0.1 (33) 0.3 (67) 0.4 (100)
CHC 21 M 28 0.1 (60) 0.1 (40) 0.2 (100)
TIDA 22 F 700 0.5 (29) 1.2 (71) 1.7 (100)